These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
799 related articles for article (PubMed ID: 23041360)
1. Survival and impact of clinical prognostic factors in surgically treated metastatic renal cell carcinoma. Tosco L; Van Poppel H; Frea B; Gregoraci G; Joniau S Eur Urol; 2013 Apr; 63(4):646-52. PubMed ID: 23041360 [TBL] [Abstract][Full Text] [Related]
2. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series. Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ; BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519 [TBL] [Abstract][Full Text] [Related]
3. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project). Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V; Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912 [TBL] [Abstract][Full Text] [Related]
5. Impact of venous tumour thrombus consistency (solid vs friable) on cancer-specific survival in patients with renal cell carcinoma. Bertini R; Roscigno M; Freschi M; Strada E; Angiolilli D; Petralia G; Matloob R; Sozzi F; Capitanio U; Da Pozzo LF; Colombo R; Guazzoni G; Cremonini A; Montorsi F; Rigatti P Eur Urol; 2011 Aug; 60(2):358-65. PubMed ID: 21640483 [TBL] [Abstract][Full Text] [Related]
6. External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology. Zigeuner R; Hutterer G; Chromecki T; Imamovic A; Kampel-Kettner K; Rehak P; Langner C; Pummer K Eur Urol; 2010 Jan; 57(1):102-9. PubMed ID: 19062157 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma. Wagner B; Patard JJ; Méjean A; Bensalah K; Verhoest G; Zigeuner R; Ficarra V; Tostain J; Mulders P; Chautard D; Descotes JL; de la Taille A; Salomon L; Prayer-Galetti T; Cindolo L; Valéri A; Meyer N; Jacqmin D; Lang H Eur Urol; 2009 Feb; 55(2):452-9. PubMed ID: 18692951 [TBL] [Abstract][Full Text] [Related]
8. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up. Olweny EO; Park SK; Tan YK; Best SL; Trimmer C; Cadeddu JA Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424 [TBL] [Abstract][Full Text] [Related]
10. Routine adrenalectomy in patients with locally advanced renal cell cancer does not offer oncologic benefit and places a significant portion of patients at risk for an asynchronous metastasis in a solitary adrenal gland. Weight CJ; Kim SP; Lohse CM; Cheville JC; Thompson RH; Boorjian SA; Leibovich BC Eur Urol; 2011 Sep; 60(3):458-64. PubMed ID: 21514718 [TBL] [Abstract][Full Text] [Related]
11. The influence of the primary tumor on the long-term results of pulmonary metastasectomy for metastatic renal cell carcinoma. Bölükbas S; Kudelin N; Eberlein M; Fisseler-Eckhoff A; Schirren J Thorac Cardiovasc Surg; 2012 Sep; 60(6):390-7. PubMed ID: 22207364 [TBL] [Abstract][Full Text] [Related]
12. Cytoreductive partial nephrectomy does not undermine cancer control in metastatic renal cell carcinoma: a population-based study. Capitanio U; Zini L; Perrotte P; Shariat SF; Jeldres C; Arjane P; Pharand D; Widmer H; Péloquin F; Montorsi F; Patard JJ; Karakiewicz PI Urology; 2008 Nov; 72(5):1090-5. PubMed ID: 18799207 [TBL] [Abstract][Full Text] [Related]
13. Impact of macroscopic tumour necrosis to predict survival of patients with surgically resected renal cell carcinoma. Pflanz S; Brookman-Amissah S; Roigas J; Kendel F; Hoschke B; May M Scand J Urol Nephrol; 2008; 42(6):507-13. PubMed ID: 19031267 [TBL] [Abstract][Full Text] [Related]
14. Impact of C-reactive protein kinetics on survival of patients with metastatic renal cell carcinoma. Saito K; Tatokoro M; Fujii Y; Iimura Y; Koga F; Kawakami S; Kihara K Eur Urol; 2009 May; 55(5):1145-53. PubMed ID: 18930583 [TBL] [Abstract][Full Text] [Related]
15. The Significance of Metastasectomy in Patients with Metastatic Renal Cell Carcinoma in the Era of Targeted Therapy. Yu X; Wang B; Li X; Lin G; Zhang C; Yang Y; Fang D; Song Y; He Z; Zhou L Biomed Res Int; 2015; 2015():176373. PubMed ID: 26568955 [TBL] [Abstract][Full Text] [Related]
16. Impact of clinical variables on predicting disease-free survival of patients with surgically resected renal cell carcinoma. Brookman-Amissah S; Kendel F; Spivak I; Pflanz S; Roigas J; Klotz T; May M BJU Int; 2009 May; 103(10):1375-80. PubMed ID: 19040527 [TBL] [Abstract][Full Text] [Related]